Intel·Protein Powder
EU & UK Protein Powder on Meta: How Brands Navigate EFSA When They Can’t Say “Build Muscle”
EFSA Regulation 432/2012 defines what protein ads can claim in Europe. We pulled the active Meta libraries for Myprotein, Form Nutrition, Free Soul, and Onyst to map the four workaround strategies brands have built around the constraint.
Key findings
- Myprotein doesn't run functional claims — it licenses confectionery brands (TWIX®, Snickers®, Krispy Kreme®) and lets flavor excitement do the acquisition work. No mention of muscle, protein synthesis, or any authorized claim.
- The most technically sophisticated move in the EU/UK set: Myprotein bundles Impact Whey with collagen peptides and Vitamin C, unlocking the EFSA-authorized “Vitamin C contributes to normal collagen formation” claim and opening beauty and skin-health creative territory a plain protein ad cannot reach.
- Form Nutrition runs zero functional claims and zero flavor collabs. Its entire Meta strategy is award stacking — “Best Protein 2024 & 2025 winner” — letting third-party validation carry the persuasion load.
- Free Soul pushes closest to the regulatory edge: “hormone-supporting superfoods” and “Voted #1 Vegan Protein Blend by VOGUE!” targeting women. The superfoods framing threads between authorized claims and non-compliant health language in ways that would draw scrutiny under stricter ASA enforcement.
EU and UK protein powder brands face a constraint US brands don't: EFSA Regulation 432/2012 defines what protein ads can say. Authorized claims exist — “Protein contributes to a growth in muscle mass,” “Protein contributes to the maintenance of muscle mass” — but they come with dose conditions and cannot be expanded into outcome language like “build lean muscle” or “burn fat.” The practical result: EU and UK brands have developed creative strategies entirely parallel to the product's core benefit. We pulled the active Meta libraries for Myprotein, Form Nutrition, Free Soul, and Onyst to map what those strategies actually look like.
Myprotein: the confectionery licensing play
Myprotein's dominant creative strategy is flavor collab licensing. The active library runs TWIX®, Snickers®, and Krispy Kreme® co-branded ads where the licensed brand does the emotional work. The copy is minimal — “New Flavor Drop: Impact Whey x TWIX®” — and the product benefit is implied rather than stated. The consumer already has a sensory relationship with TWIX®; Myprotein borrows that relationship and attaches it to a protein product without having to make any claim about what the protein does.
Myprotein · Flavor collab · Primary campaign
“New Flavor Drop: Impact Whey x TWIX®”
Myprotein · UK · 30 active ads · Flavor collab series: TWIX®, Snickers®, Krispy Kreme® · No functional claims in any active creative
This strategy sidesteps the EFSA constraint entirely. There's no claim to scrutinize because there's no claim. The creative operates as brand and flavor marketing — closer to a confectionery launch than a supplement ad — and runs without touching the authorized claim framework at all. The tradeoff is that it doesn't build any functional differentiation. A consumer who buys based on the TWIX® collab has no particular reason to stay loyal to Impact Whey once the flavor novelty fades.
Myprotein: the collagen bundle workaround
The more technically interesting Myprotein strategy is a separate product line bundling Impact Whey with collagen peptides and added Vitamin C. The creative for this product leads with a skin and beauty angle — “20g protein, including 10g from collagen peptides + added vitamin C. High-quality, versatile, and ready to go” — and the Vitamin C inclusion is not incidental.
Under EFSA Regulation 432/2012, “Vitamin C contributes to normal collagen formation for the normal function of skin” is an authorized claim. By bundling whey with collagen peptides and Vitamin C, Myprotein gains regulatory cover to run beauty and wellness adjacent ads that a plain protein product cannot legally run. The same SKU can be advertised to a fitness audience on protein and to a beauty audience on skin — two different creative territories, one product.
Myprotein Collagen + Whey · Beauty angle · Secondary campaign
“20g protein, including 10g from collagen peptides + added vitamin C.”
Myprotein · UK · Collagen Whey product · Routes to beauty/skin creative via EFSA-authorized Vitamin C → collagen formation claim
Form Nutrition: awards as social proof
Form Nutrition's active library takes a different path: no flavor collabs, no ingredient bundling, no claim language of any kind. Its Meta creative is built entirely on award stacking. The hero message across approximately 14 active ads is “Best Protein 2024 & 2025 winner” — an industry award that functions as a third-party endorsement without making any first-person health claim.
Form Nutrition · Award positioning · All active creative
“Best Protein 2024 & 2025 winner.”
Form Nutrition · UK · ~14 active ads · Zero functional claims · Third-party award as primary persuasion mechanism
The award framing is legally clean because the claim belongs to the award body, not to Form. It also carries quality signals without requiring the brand to explain what “quality” means at the ingredient or mechanism level — a useful shortcut in a category where the functional story is tightly constrained. The strategic question it raises: how much acquisition lift does an industry award actually generate among consumers who don't know which body issued it?
Free Soul: women's positioning at the edge
Free Soul targets women explicitly — “Uniquely formulated for women” — and runs a magazine endorsement as its anchor: “Voted #1 Vegan Protein Blend by VOGUE!” Like Form, it uses third-party validation to carry the persuasion load. But it also pushes further into ingredient language, describing the formula as containing “hormone-supporting superfoods.”
Free Soul · Women's positioning · Primary campaign
“Voted #1 Vegan Protein Blend by VOGUE!”
Free Soul · UK · Women's protein · “hormone-supporting superfoods” and “Uniquely formulated for women” · Vogue endorsement as primary social proof
“Hormone-supporting” is not an authorized claim under EFSA Regulation 432/2012. There is no authorized claim for protein or any common protein blend ingredient that references hormone function in women. The superfoods framing provides some cover — “this ingredient supports X” can be argued as general nutritional language — but it occupies contested ground. Under active ASA enforcement, this language would invite scrutiny. The brand appears to be wagering that the enforcement risk is lower than the creative benefit of the hormone framing for a women's audience.
Onyst: the attack angle
Onyst runs a contrarian creative frame, positioning against conventional protein powders rather than competing within the category on flavor or award credentials. Its active creative uses attack copy — implying that standard protein products cause gut discomfort — and leads with a gut-to-joint benefit stack: the product “helps in supporting the health of your gut wall, skin, hair, nails and joints.”
The gut wall, skin, hair, nails, and joints framing is not supported by authorized EFSA claims for protein or for any typical protein blend ingredient. This language would need Vitamin C or specific collagen authorization to run cleanly — similar to the Myprotein collagen bundle strategy, but without the explicit Vitamin C inclusion to anchor it. Unlike Myprotein, Onyst's creative doesn't appear to route through an authorized claim pathway. It runs the benefit language directly.
What this means for the category
The EU and UK protein powder category has developed four distinct workaround strategies for the EFSA constraint: licensed brand excitement (Myprotein flavor collabs), ingredient bundling to unlock adjacent authorized claims (Myprotein collagen + Vitamin C), third-party validation as a claim substitute (Form, Free Soul), and direct benefit language that runs without clear regulatory cover (Free Soul's hormone framing, Onyst's gut/joint stack). The most legally robust strategies are also the most product-agnostic — a Krispy Kreme® collab and an award sticker don't differentiate the formula. The brands that differentiate the formula are the ones running closest to the regulatory edge.
The collagen bundle is the most replicable strategy in the set
Myprotein's Vitamin C pathway is a legitimate regulatory route, not a grey-area gamble. Any brand adding collagen peptides and Vitamin C to a protein blend gains access to authorized skin and collagen formation claims under EFSA 432/2012 — and with it, a second distinct creative territory (beauty, wellness, skin health) that a plain protein product cannot enter. The product development cost is low; the creative flexibility gained is significant.
Award credentialing works until everyone has one
Form Nutrition and Free Soul both lead with external endorsements — an industry award and a Vogue vote respectively. This strategy is clean and scalable while the credential is rare. As more brands accumulate “best protein” awards from various bodies, the signal degrades. The brands using this approach now have a time-limited advantage that depends on the award remaining distinctive.
The hormone and gut language is the live risk in the category
Free Soul's “hormone-supporting superfoods” and Onyst's gut wall and joint language are both running without clear EFSA authorized claim anchors. Under active ASA enforcement, both would draw complaints. Neither brand appears to have a collagen-plus-Vitamin-C pathway that would legitimize the claims. The brands running this language are generating acquisition metrics that don't account for regulatory exposure.
The flavor collab strategy has a loyalty ceiling
Myprotein's confectionery collab creative drives acquisition on novelty and brand recognition. It doesn't build any functional reason to stay. A customer who bought TWIX® Impact Whey has no claimed protein quality signal, no formula differentiation, no authorized benefit that makes the repurchase feel necessary. For a subscription product, the acquisition-to-retention gap this creates is a structural problem the flavor rotation strategy doesn't solve.
Related intelligence
For the US side of this story — where DSHEA removes the EFSA constraint entirely and protein brands run fat loss, mTOR activation, and competitor-naming advertorials — see the US Protein Powder Meta Ads report.
Run your own
Want this kind of breakdown on your own competitor set? Snapshots pull any brand’s active Meta ads and structure the data for you.
See how Snapshots work →